Haleon plc on Thursday announced it has released its trading statement for the third quarter of 2025.
The consumer health company, which owns brands such as Sensodyne and Advil, did not include financial highlights in its initial regulatory filing.
According to the company, the full statement has been made available on its investor website and submitted to the UK's Financial Conduct Authority.
Haleon said its Chief Financial Officer, Dawn Allen, will host a presentation and a question-and-answer session for analysts and shareholders on Thursday morning.
An archived webcast of the event will be made available on the company's website later in the day, the company added.
More from this issuer
Related coverage
Haleon on Monday announced that its chairman, Sir Dave Lewis, will step down at the end of the year to pursue a new executive role.